The global hyperammonemia treatment market size is expected to reach a valuation of USD 1,318.05 Million in 2023 and is projected to reach USD 2,100 Million by 2033, trailing a CAGR of 4.77%. The rising prevalence of urea cycle disorders and extensive research and development are the primary factors driving the growth of Hyperammonemia treatment …